GSM1402565|patient #6|N/A|N/A|N/A|N/A|Mantle Cell Lymphoma|Whole Blood|N/A|in_vivo|ctrl|Before Bortezomib|Bortezomib|Disease
GSM1402566|patient #2|N/A|N/A|N/A|N/A|Mantle Cell Lymphoma|Whole Blood|N/A|in_vivo|case|96-hour after Bortezomib|Bortezomib|Disease
GSM1402567|patient #1|N/A|N/A|N/A|N/A|Mantle Cell Lymphoma|Whole Blood|N/A|in_vivo|case|96-hour after Bortezomib|Bortezomib|Disease
GSM1402568|patient #4|N/A|N/A|N/A|N/A|Mantle Cell Lymphoma|Whole Blood|N/A|in_vivo|case|96-hour after Bortezomib|Bortezomib|Disease
GSM1402569|patient #6|N/A|N/A|N/A|N/A|Mantle Cell Lymphoma|Whole Blood|N/A|in_vivo|case|96-hour after Bortezomib|Bortezomib|Disease
GSM1402570|patient #5|N/A|N/A|N/A|N/A|Mantle Cell Lymphoma|Whole Blood|N/A|in_vivo|case|96-hour after Bortezomib|Bortezomib|Disease
GSM1402571|patient #3|N/A|N/A|N/A|N/A|Mantle Cell Lymphoma|Whole Blood|N/A|in_vivo|case|96-hour after Bortezomib|Bortezomib|Disease
GSM1402572|patient #1|N/A|N/A|N/A|N/A|Mantle Cell Lymphoma|Whole Blood|N/A|in_vivo|ctrl|Before Bortezomib|Bortezomib|Disease
GSM1402573|patient #2|N/A|N/A|N/A|N/A|Mantle Cell Lymphoma|Whole Blood|N/A|in_vivo|ctrl|Before Bortezomib|Bortezomib|Disease
GSM1402574|patient #3|N/A|N/A|N/A|N/A|Mantle Cell Lymphoma|Whole Blood|N/A|in_vivo|ctrl|Before Bortezomib|Bortezomib|Disease
GSM1402575|patient #4|N/A|N/A|N/A|N/A|Mantle Cell Lymphoma|Whole Blood|N/A|in_vivo|ctrl|Before Bortezomib|Bortezomib|Disease
GSM1402576|patient #5|N/A|N/A|N/A|N/A|Mantle Cell Lymphoma|Whole Blood|N/A|in_vivo|ctrl|Before Bortezomib|Bortezomib|Disease